The application of NLC-Pip on MCF-7 breast tumor cells caused a significant increase in apoptosis of ~8×, while NLC-Pip–BSA was shown to have an 11-fold increase in apoptosis compared to untreated cells. This evidence concerns the gene PIP and breast neoplasm.